NEW YORK (GenomeWeb) – Abbott today said that its Diagnostics business revenues grew 47 percent year over year in the second quarter, driven by sales in its rapid diagnostics business, which reflect results for Alere acquired in October 2017.

On an organic basis, without rapid diagnostics sales, Abbott's worldwide diagnostics sales increased 7 percent, driven by strong core lab and MDx sales.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.